Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merit Medical Sys (NQ: MMSI )

81.44 +0.49 (+0.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 120,518
Open 81.17
Bid (Size) 79.54 (1)
Ask (Size) 83.47 (1)
Prev. Close 80.95
Today's Range 80.72 - 81.87
52wk Range 50.46 - 85.39
Shares Outstanding 57,493,643
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 5 Health Care Stocks That Should Keep You Up At Night
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Analyst Ratings for Merit Medical Systems
 
Via Benzinga

Performance

YTD
+17.01%
+17.01%
1 Month
+0.18%
+0.18%
3 Month
+15.71%
+15.71%
6 Month
+16.08%
+16.08%
1 Year
+32.66%
+32.66%

More News

Read More
Chart Of The Day: Merit Medical Systems - Strong Buy Sentiment
Via Talk Markets
Merit Medical To See Sustained Revenue Growth Despite Macro Headwinds, Bullish Analyst Says
Via Benzinga
Analyst Ratings for Merit Medical Systems
Via Benzinga
Lantheus Holdings Stock Showing Market Leadership; Earns 94 RS Rating
Via Investor's Business Daily
Merit Medical Systems: Q3 Earnings Insights
Via Benzinga
Earnings Scheduled For October 28, 2021
Via Benzinga
Earnings Scheduled For February 22, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
Via Benzinga
A Preview Of Merit Medical Systems's Earnings
Via Benzinga
Recap: Merit Medical Systems Q2 Earnings
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Merit Medical Bullish On FY23 Operating Margin Of 18-21%, Needham Says Could Exceed
Via Benzinga
Merger Arbitrage Mondays - Google (GOOG) Acquires Cybersecurity Firm Mandiant (MNDT)
Via Benzinga
Medical Device Maker Merit Medical Mulls Sale: Reuters
Via Benzinga
Recap: Merit Medical Systems Q4 Earnings
Via Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Via Benzinga
Merit Medical Systems Inc (MMSI) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
Via Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Via Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.